Perrigo (PRGO) EBITDA Margin (2012 - 2026)
Perrigo's (PRGO) quarterly EBITDA Margin came in at 2.3% in Q2 2026, down 200.0% year-over-year from 2.3% in Q2 2025, and up 105.98% quarter-over-quarter from 38.41% in Q1 2026.
Analysis
Perrigo (PRGO) EBITDA Margin (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported EBITDA Margin for 15 consecutive years, with 2.3% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 200.0% year-over-year to 2.3% in Q2 2026; TTM through Jun 2026 was 37.72%, a 4435.0% decrease from a year earlier, with the FY2025 full-year figure at 26.39%, down 2897.0% from the prior year.
- EBITDA Margin was 2.3% for Q2 2026 at Perrigo, up from 38.41% in the prior quarter.
- Over five years, EBITDA Margin peaked at 10.03% in Q4 2024 and troughed at 116.0% in Q4 2025.
- A 5-year average of 5.91% and a median of 2.85% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 1222 bps in 2022 and plunged 12603 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 2.68% in 2022, then tumbled by 150 bps to 1.35% in 2023, then soared by 844 bps to 10.03% in 2024, then tumbled by 1256 bps to 116.0% in 2025, then jumped by 102 bps to 2.3% in 2026.
- The last three EBITDA Margin figures came in at 2.3% (Q2 2026), 38.41% (Q1 2026), and 116.0% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 2.30% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 9.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 4.39% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 11.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 2.30% |
| Mar 28, 2026 | -38.41% |
| Dec 31, 2025 | -116.00% |
| Sep 27, 2025 | 6.96% |
| Jun 28, 2025 | 4.30% |
| Mar 29, 2025 | 4.49% |
| Dec 31, 2024 | 10.03% |
| Sep 28, 2024 | 7.39% |
| Jun 29, 2024 | -2.49% |
| Mar 30, 2024 | -5.10% |
| Dec 31, 2023 | -1.35% |
| Sep 30, 2023 | 5.53% |
| Jul 1, 2023 | 4.76% |
| Apr 1, 2023 | 4.10% |
| Dec 31, 2022 | 2.68% |
| Oct 1, 2022 | 3.01% |
| Jul 2, 2022 | -0.62% |
| Apr 2, 2022 | 2.02% |
| Dec 31, 2021 | 4.23% |
| Oct 2, 2021 | 42.04% |